Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers

Cytogenet Genome Res. 2016;150(3-4):208-216. doi: 10.1159/000455753. Epub 2017 Feb 16.

Abstract

FHIT, located at FRA3B, is one of the most commonly deleted genes in human cancers, and loss of FHIT protein is one of the earliest events in cancer initiation. However, location of FHIT at a chromosomal fragile site, a locus prone to breakage and gap formation under even mild replication stress, has encouraged claims that FHIT loss is a passenger event in cancers. We summarize accumulated evidence that FHIT protein functions as a genome "caretaker" required to protect the stability of genomes of normal cells of most tissues from agents causing intrinsic and extrinsic DNA damage. FHIT loss leads to intracellular replication stress and subsequent genome instability, which provides an opportunistic mutational landscape in preneoplasias for selection of a variety of other cancer-driving mutations. We also review evidence showing that FHIT loss leads to enhanced activation of other common fragile sites, including the FRA16D/WWOX locus, and creates optimal single-stranded DNA substrates for the hypermutator enzyme, APOBEC3B.

Publication types

  • Review

MeSH terms

  • Acid Anhydride Hydrolases / genetics
  • Chromosome Fragile Sites*
  • Genes, p53
  • Genomic Instability
  • Humans
  • Mutation
  • Neoplasm Proteins / genetics
  • Neoplasms / genetics*
  • Oxidoreductases / genetics
  • Precancerous Conditions / genetics
  • Tumor Suppressor Proteins / genetics
  • WW Domain-Containing Oxidoreductase

Substances

  • Neoplasm Proteins
  • Tumor Suppressor Proteins
  • fragile histidine triad protein
  • Oxidoreductases
  • WW Domain-Containing Oxidoreductase
  • WWOX protein, human
  • Acid Anhydride Hydrolases